Connection
David Simpson to Anti-Dyskinesia Agents
This is a "connection" page, showing publications David Simpson has written about Anti-Dyskinesia Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.057 |
|
|
|
-
Gracies JM, Bayle N, Goldberg S, Simpson DM. Botulinum toxin type B in the spastic arm: a randomized, double-blind, placebo-controlled, preliminary study. Arch Phys Med Rehabil. 2014 Jul; 95(7):1303-11.
Score: 0.462
-
Simpson DM. Treatment of spasticity with botulinum toxin. Muscle Nerve. 2000 Apr; 23(4):447-9.
Score: 0.175
-
Spiera H, Asbell PA, Simpson DM. Botulinum toxin increases tearing in patients with Sj?gren's syndrome: a preliminary report. J Rheumatol. 1997 Sep; 24(9):1842-3.
Score: 0.146
-
Simpson DM. Clinical trials of botulinum toxin in the treatment of spasticity. Muscle Nerve Suppl. 1997; 6:S169-75.
Score: 0.140
-
Simpson DM, Alexander DN, O'Brien CF, Tagliati M, Aswad AS, Leon JM, Gibson J, Mordaunt JM, Monaghan EP. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology. 1996 May; 46(5):1306-10.
Score: 0.133